SCYXSCYNEXIS, Inc.
$4.19-34% 1Y
$4.19
$3.5752 weeks$8.88
Is the price fair?
What SCYX's price assumes
SCYNEXIS, Inc. has no trailing P/E on file, so the price is measured against sales instead: 28.6× revenue.
28.6
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 14.1
Price / book · as of 2026-Q1
- EV / sales
- 26.9
EV / sales
Details›
- Price / bookas of 2026-Q1
- 14.1
- EV / salesas of 2026-Q1
- 26.9
- Market capitalisation
- $333M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry